Tuberculosis (TB) Toolbox

Under the coordination of the Nunavik Public Health Department, this TB toolbox brings together all the tuberculosis assessment and follow-up protocols and documents used at regional level in Nunavik's two health centers.

Its objectives are to :

  • standardize tuberculosis clinical and public health practice guidelines at regional level;
  • support and guide the interventions of the various professionals involved in tuberculosis control.

It is the fruit of consultation and consensus-building between all institutional and professional partners involved in the regional fight against tuberculosis.

This TB toolbox is regularly updated and improved with the gradual addition of new tools.

Definition of a priority village :

Village with the highest risk of recent TB transmission, based on epidemiological indicators such as the number of recent smear-positive TB cases in the community, the number of recent infections that have been identified, and the historical burden of TB and LTBI. Each village is assigned a score based on these indicators and adjusted according to its population size; on this basis, a village can then be classified as a "priority village" for tuberculosis.

List of priority villages drawn up by the Public Health Department:

  • Puvirnituq
  • Akulivik
  • Salluit
  • Kangiqsualujjuaq
  • Kangiqsujuaq
  • Inukjuak
  • Ivujivik
1st publicationUpdated
Roles and responsibilities of TB interveners in Nunavik2023-10-022023-10-01
Guide to use of TB tools: Dashboard2023-10-022023-10-01
Prescription of LTBI medication1st publicationUpdated
Prescription of LTBI medication – 3HP2024-04-172024-04-16
Prescription of LTBI medication - RIF2023-10-022024-03-14
Prescription of LTBI medication – INH DOT2023-10-022024-03-14
Prescription of LTBI medication – INH daily2023-10-022024-03-14
Prescription of LTBI medication – 3HP window-period2024-04-172024-04-16
Prescription of LTBI medication - RIF window-period2023-10-022024-03-14

LTBI follow-up protocols
  
Follow-up protocol – 3HP2024-04-172024-09-03
Follow-up protocol - RIF2023-10-022024-09-03
Follow-up protocol – INH Daily and DOT2023-10-022024-09-03
Follow-up protocol – 3HP window-period2024-04-172024-04-16
Follow-up protocol – RIF window-period2023-10-022023-10-01

Registration of the LTBI medication
  
Registration of the medication – 3HP2024-04-172024-09-10
Registration of the medication - RIF2023-10-022023-10-01
Registration of the medication – INH DOT2023-10-022023-10-01
Registration of the medication – INH daily2023-10-022023-10-01

Compliance curve
  
Compliance curve – RIF2023-10-022024-05-17
Compliance curve – INH daily2023-10-022024-05-17

Clinical assessment
  
Adverse reactions of the main TB treatments2023-10-022025-06-01
Weekly clinical assessment – 3HP2024-04-172024-04-16
Monthly clinical assessment – RIF / INH DIE / INH TOD2020-03-252023-10-02

Clinical and radiological follow-up
  
Clinical and radiological follow-up guide2023-10-022024-08-27
STANDARD clinical and radiological follow-up - Clinical evaluation and medical action2023-10-022023-10-01
ADDITIONAL clinical and radiological follow-up - Clinical evaluation and medical action2023-10-022023-10-01
Déclaration MADO1st publicationUpdated
Reportable diseases form (available in French only)2023-10-022023-10-01
Reportable diseases form – dynamic version (available in French only)2023-10-022023-10-01

Support measures
  
Support measures to promote adherence to the active tuberculosis treatment plan2024-12-162024-12-16

Appendix 4
  
Appendix 42023-10-022023-10-01

Identification of contacts of an active TB case
  
Procedure for identification of contacts of an active TB case2023-10-252023-10-01
Identification of contacts of an active TB case2023-10-022024-01-18

Commitment contract
  
Procedure for commitment contract relative to mandatory treatment2023-10-022023-10-01
Commitment contract relative to mandatory treatment 2023-10-022023-10-01

Home isolation
  
Reference Guide - Home isolation2024-12-162024-12-16

Prescription of active TB medication
  
--Adult--  
Prescription of active TB medication – Phase 1 - Adult2023-10-022024-03-14
Prescription of active TB medication – Phase 2 - Adult2023-10-022024-03-14
--Child--  
Prescription of active TB medication – Phase 1 - Child2023-10-022024-05-14
Prescription of active TB medication – Phase 2 - Child2023-10-022024-03-14

Active TB follow-up protocol
  
Active TB follow-up protocol2023-10-022024-09-03

Registration of the active TB medication
  
Procedure - Registration of the active TB medication2023-10-012023-04-04
Registration of the active TB medication – Phase 12023-10-022023-10-01
Registration of the active TB medication – Phase 22023-10-022023-10-01

Monthly clinical assessment
  
Adverse reactions of the main TB treatments2023-10-022025-06-01
Monthly clinical assessment2023-10-022023-10-01

Treatment outcome
  
Treatment outcome2023-10-022023-10-01

Clinical and radiological follow-up
  
Clinical and radiological follow-up guide2023-10-022024-08-27
STANDARD clinical and radiological follow-up - Clinical evaluation and medical action2023-10-022023-10-01
ADDITIONAL clinical and radiological follow-up - Clinical evaluation and medical action2023-10-022023-10-01

The tools contained in this section are reserved for use in a mass screening context only, according to the communities targeted below.

Mass (or population) screening applies to an entire population or a large group of them, is characterized by the absence of individual selection criteria, and is organized as part of a public health campaign.

It thus differs from individual screening, which is indicated by criteria specific to the individual, such as exposure to a person with active TB or the presence of TB symptoms.

How to access:
All courses are hosted on the Digital Learning Environment (ENA) platform.

To log on:

  1. Use your Windows account details, the same as those used to log on to your work computer (e.g. ABCD1911 or ABCDEF01). If you do not have one, you must request one from your health centre’s IT department, following the usual procedure.
  2. And in the “Institution name” list, select Region 17 - Nunavik / RRSSSN - CSI - CSTU;

Training path:
Several training paths are available depending on your professional profile.

For more details, see:

To receive an alert when a tool is updated or when a new tool is added, register on our mailing list by sending an e-mail to: aurelie.heurtebize@ssss.gouv.qc.ca